Antibody targeting of the TNF–TNFR2 axis to overcome tumor immune resistance - Quiz - MDSpire

Antibody targeting of the TNF–TNFR2 axis to overcome tumor immune resistance

  • By

  • Xiaozhen Kang

  • Xiangmin Tong

  • Shibing Wang

  • May 14, 2026

Share

Original Source(s)

Related Content